Brainscape's Knowledge GenomeTM

Browse over 1 million classes created by top students, professors, publishers, and experts.


See full index

Endocrine System > Lecture 21: Management of Type 2 Diabetes Mellitus > Flashcards

Lecture 21: Management of Type 2 Diabetes Mellitus Flashcards

1
Q

what investigations and support should a type 2 diabetic patient expect from their care?

list

A
  • blood glucose level monitoring
  • blood pressure monitoring
  • blood lipids monitoring
  • eyes screened
  • feet checked
  • kidney function checks
  • weight
  • smoking cessation support
  • individual care plan
  • education course
  • emotional and psychological support
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

which drugs are offered to increase insulin release in type 2 diabetes?

list

A
  • sulphonylureas
  • metiglinides
  • incretin mimetics
  • DPPIV inhibitors
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

which group of drugs are used to increase excretion of glucose?

A

SGLT2 inhibitors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

which treatments are used to improve insulin action in type 2 diabetics?

list

A
  • biguanides
  • thiazolidiones
  • weight reduction
  • physical activity
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

5 step framework for choosing a glucose lowering drug

A
  1. Set a target HbA1c
  2. ‘Take 5’ are there other risk factors that should also be treated?
  3. Are the current treatments optimised? Max dose? Tolerated? Taken?
  4. What are the glucose lowering options? > remove any that are contraindicated, of the remaining what are the pros and cons, select the preffered choice?
  5. Agree a review date and the target HbA1c with the patient.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

why is metformin normally the first choice of medication used to treat type 2 diabetes?

A
  • improves outcomes
  • well-tolerated
  • cheap
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

what class of drug is metformin?

A

biguanide

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

how does metformin work?

A

Improves insulin sensitivity:
- affects glucose production, decreased fatty acid synthesis
- improves insulin receptor function
- inhibits gluconeogenic pathways

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

what is the half-life of metformin?

A

6 hours

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

list the advantages of metformin

A
  • improves CV outcomes and mortality in obese T2 DM patients.
  • efficaceous: used alone can decrease fasting blood blucose by 22-26%.
  • normally well tolerated
  • not associated with weight gain
  • HbA1c by 12-17% reduction
  • also used in pregnancy
  • cheap
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

disadvantages/side-effects of metformin

A
  • GI side effects 20-30%
  • risk of lactic acidosis by inhibiting lactic acid uptake by liver: hypoxia, renal failure, hepatic failure, alcohol abuse
  • risk vitamin B12 malabsorption
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

give examples of sulphonylureas

A

The ‘Gli….ides’:
- Glimerpiride
- Gliclazide
- Glipizide

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

when are sulphonylureas indicated?

A
  • if osmotic symptoms or HbA1c increasing rapidly titration based on home blood glucose monitoring.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

target tissue of metformin

A

liver

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

target tissue of sulphonylureas

A

pancreas

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

mechanism of action of sulphonylureas

A

Increases insulin release:
- binds to sulfonylurea receptors (SUR-1) on functioning pancreatic beta-cells.
- binding closes the ATP sensitive K+ channels.
- decreased potassium influx depolarisation of the beta-cell membrane.
- voltage-dependent calcium channels open and result in an influx of calcium.
- causes translocation and exocytosis of secretory granyles of insulin to the cell surface.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

advantages of sulphonylureas

A
  • rapid improvement in blood glucose control
  • rapid improvement if symptomatic
  • rapid titration
  • cheap
  • generally well-tolerated
18
Q

disadvantages of sulphonylureas

A
  • risk of hypoglycaemia
  • weight gain
  • caution in renal and hepatic disease
  • CI in pregnancy and breastfeeding
  • Side effects: hypersensitivity and photosensitivity reactions, blood disorders.
19
Q

target tissues of thiazolidinediones (‘…glitazones’)

A

adipose tissue
liver
muscle

20
Q

mechanism of Pioglitazone

a thiazolidinedione

A

Improves insulin action:
- reduces insulin sensitivity in the liver and peripheral tissues
- increases the expense of insulin-dependent glucose
- decreases withdrawal of glucose from the liver
- reduces quantity of glucose, insulin and glycated haemoglobin in the bloodstream.

21
Q

pioglitazone advantages

A
  • good for people if insulin resistance significant
  • HbA1c reduced by 0.6-1.3%
  • cheap
  • cardiovascular safety established
22
Q

pioglitazone disadvantages

A
  • increased risk of bladder cancer
  • fluid retention - CCF
  • weight gain
  • small increased risk of fractures in females
23
Q

supplementary insulin therapy drug names

A

Isophane insulin:
- Humulin I
- H insulatard

once daily injection, usually at bedtimes

24
Q

list examples of SGLT2 inhibitors

A

’..gliflozins’:
- canagliflozin
- dapagliflozin
- empagliflozin

25
Q

how do SGLT2 inhibitors work?

A
  • they selectively inhibit SGLT2 in the renal proximal tubule, preventing the reabsorption of glucose into the bloodstream.
  • increases urinary glucose excretion.
26
Q

effects of SGLT2 inhibitors

positive and negative

A
  • gets rid of glucose/more glycosuria > lowers HbA1c
  • gets rid of water/osmotic diuresis > can cause (postural) hypotension and dehydration
  • gets rid of calories/wastes glucose > lose weight with same intake
  • gets rid of sodium/less reuptake > lowers systolic blood pressure
  • greater risk of urogenital infection > cystitis and cadidiasis
27
Q

what is the 1st line therapy for those with a high CV risk when metformin not tolerated?

A

SGLT2 inhibitors

28
Q

what is the 2nd line therapy in those at high CV risk (started immediately after metformin tolerability established)?

A

SGLT2 inhibitors

29
Q

advantages of SGLT2 inhibitors

A
  • weight loss
  • no risk of hypoglycaemia
  • good effects on glycemic control
  • beneficial effect on CV morbidity and mortality and renal outcomes
  • 2nd or 3rd line agents
  • can add to insulin regimens in T2DM
30
Q

disadvantages of SGLT2 inhibitors

A
  • expensive
  • side effects: UTI, fungal infections, osmotic symptoms
  • risk of digital amputation
  • risk of diabetic ketoacidosis (DKA)
  • contraindicated in pregnancy and breastfeeding
  • cannot use in renal impairment
31
Q

Give examples of DPPIV inhibitors

incretin mimetics

A

…Gliptins:
- saxagliptin
- sitagliptin
- vildagliptin

32
Q

mechanism of action of gliptins (DPPIV inhibitors)

A

delay the breakdown of incretins such as GLP1 and GIP and thereby increase active incretin levels > stimulate pancreatic B cells > secretion of insulin

33
Q

DPPIV inhibitors (gliptins) advantages

A
  • usually well-tolerated
  • can be used as 2nd or 3rd line agent
  • can be used in renal impairment
  • no risk of hypoglycaemia
  • weight neutral
34
Q

DPPIV inhibitors (gliptins) disadvantages

A
  • trial data shows relatively small effects on glycemic control
  • contraindicated in pregnancy and breastfeeding
  • side effects: nausea
35
Q

give examples of GLP-1 analogues

incretin mimetics

A

‘…tides’:
- exenatide
- liraglutide
- lixisenatide

36
Q

mechanism of actions of GLP1 analogues

A

act as incretin mimetic > stimulates pancreatic B-cells to secrete insulin
- resistant to enzymatic degredation
- greatly prolonged biological half-life

37
Q

GLP-1 analogues advantages

A
  • weight loss
  • no risk of hypoglycaemia
  • 3rd line agent
  • can be used with basal insulin
  • some have benfit for CV disease
38
Q

GLP-1 analogues disadvantages

A
  • injection
  • expensive
  • contraindicated in pregnancy and breastfeeding
  • side effetcs: nausea and vomiting
39
Q

For adults whose type2 diabetes is managed either by lifestyle and diet, or lifestyle and diet combined with a single drug not associated with hypoglycaemia, support them to aim for an HbA1c level of…

A

48 mmol/mol

40
Q

For adults on a drug associated with hypoglycaemia, support them to aim for an HbA1c level of

A

53mmol/mol

41
Q

In adults with type2 diabetes, if HbA1c levels are not adequately controlled by a single drug and rise to 58mmol/mol (7.5%) or higher, what is the course of action?

A
  • reinforce advice about diet, lifestyle and adherence to drug treatmentand
  • support the person to aim for an HbA1c level of 53mmol/mol (7.0%)and
  • intensify drug treatment.
42
Q

Consider relaxing the target HbA1c level on a case-by-case basis and in discussion with adults with type2 diabetes, with particular consideration for people who are older or frailer, if:

A
  • they are unlikely to achieve longer-term risk-reduction benefits, for example, people with a reduced life expectancy
  • tight blood glucose control would put them at high risk if they developed hypoglycaemia, for example, if they are at risk of falling, they have impaired awareness of hypoglycaemia, or they drive or operate machinery as part of their job
  • intensive management would not be appropriate, for example if they have significant comorbidities.[2015, amended 2022]

Endocrine System (29 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2024 Bold Learning Solutions. Terms and Conditions